Abstract
Electroporation/electropermeabilization (EP), achieved by application of electric pulses to cells or tissues, induces reversible permeabilization of cell membranes under suitable conditions, thus facilitating entry of exogenous molecules into cells. EP of tissues in humans is feasible, efficient, and tolerable, and its most advanced routine clinical use is electrochemotherapy (ECT), where cytotoxic drugs are delivered to cells to treat tumors. It is increasingly used in different tumor types, and the technology is being adopted for the treatment of deep-seated tumors like liver, pancreas, and bone metastases and colon tumors. Although the primary mode of action of ECT is the destruction of tumor cells due to the increased cytotoxicity of chemotherapeutic drugs, it also has different effects on the tissue level. It was shown that EP and ECT have blood flow-modifying effects on normal as well as on tumor vasculature. Application of EP pulses to normal blood vessels increases the permeability of affected blood vessels; causes a transient vascular lock, i.e., decrease in perfusion; and modulates the diameter of affected blood vessels. Similarly, in tumors, application of EP or ECT increases the permeability of affected blood vessels and causes a vascular lock. In case of normal blood vessels, these effects are short lived, whereas in case of tumor blood vessels, the effects are long lasting and resolve more than 24 h after ECT. Moreover, ECT has a direct cytotoxic effect on tumor endothelial cells; thus it has a vascular-disrupting effect. This effect is differential, destroying only tumor blood vessels and retaining the functionality of normal blood vessels surrounding the tumor, which is important when ECT is used in well-perfused organs such as the liver.
Similar content being viewed by others
References
Barker HE, Paget JTE, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15:409–425. doi:10.1038/nrc3958
Bellard E, Markelc B, Pelofy S, Le Guerroué F, Sersa G, Teissié J, Cemazar M, Golzio M (2012) Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. J Control Release 163:396–403
Cemazar M, Parkins CS, Holder AL, Chaplin DJ, Tozer GM, Sersa G (2001) Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer 84:565–570. doi:10.1054/bjoc.2000.1625
Clémenson C, Chargari C, Deutsch E (2013) Combination of vascular disrupting agents and ionizing radiation. Crit Rev Oncol Hematol 86:143–160. doi:10.1016/j.critrevonc.2012.10.002
Folkman J (2007) Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 6:273–286. doi:10.1038/nrd2115
Gehl J, Geertsen PF (2000) Efficient palliation of haemorrhaging malignant melanoma skin metastases by electrochemotherapy. Melanoma Res 10:585–589
Gehl J, Skovsgaard T, Mir LM (2002) Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569:51–58
Gothelf A, Gehl J (2012) What you always needed to know about electroporation based DNA vaccines. Hum Vaccin Immunother 8:1694–1702. doi:10.4161/hv.22062
Jarm T, Cemazar M, Miklavcic D, Sersa G (2010) Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 10:729–746. doi:10.1586/era.10.43
Kanthou C, Kranjc S, Sersa G, Tozer G, Zupanic A, Cemazar M (2006) The endothelial cytoskeleton as a target of electroporation-based therapies. Mol Cancer Ther 5:3145–3152. doi:10.1158/1535-7163.MCT-06-0410
Marcan M, Kos B, Miklavcic D (2015) Effect of blood vessel segmentation on the outcome of electroporation-based treatments of liver tumors. PLoS One 10, e0125591. doi:10.1371/journal.pone.0125591
Markelc B, Bellard E, Sersa G, Pelofy S, Teissie J, Coer A, Golzio M, Cemazar M (2012) In vivo molecular imaging and histological analysis of changes induced by electric pulses used for plasmid DNA electrotransfer to the skin: a study in a dorsal window chamber in mice. J Membr Biol 245:545–554. doi:10.1007/s00232-012-9435-5
Markelc B, Sersa G, Cemazar M (2013) Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One 8, e59557. doi:10.1371/journal.pone.0059557
Meulenberg CJW, Todorovic V, Cemazar M (2012) Differential cellular effects of electroporation and electrochemotherapy in monolayers of human microvascular endothelial cells. PLoS One 7, e52713. doi:10.1371/journal.pone.0052713
Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J, Munck JN, Mir LM (1998) Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77:2104–2111
Rems L, Miklavcic D (2016) Tutorial: electroporation of cells in complex materials and tissue. J Appl Phys 119:201101. doi:10.1063/1.4949264
Sersa G, Beravs K, Cemazar M, Miklavcic D, Demsar F (1998) Contrast enhanced MRI assessment of tumor blood volume after application of electric pulses. Electro Magnetobiol 17:299–306. doi:10.3109/15368379809022574
Sersa G, Cemazar M, Miklavcic D, Chaplin DJ (1999) Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 19:4017–4022
Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, Coer A, Swartz HM, Cemazar M (2002) Reduced blood flow and oxygenation in SA-1 tumours after electrochemotherapy with cisplatin. Br J Cancer 87:1047–1054. doi:10.1038/sj.bjc.6600606
Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, Miklavcic D, Kadivec M, Kranjc S, Secerov A, Cemazar M (2008) Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 98:388–398. doi:10.1038/sj.bjc.6604168
Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D (2014) Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 16:295–320. doi:10.1146/annurev-bioeng-071813-104622
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Sersa, G., Cemazar, M., Markelc, B. (2016). Blood Flow Modifying and Vascular-Disrupting Effects of Electroporation and Electrochemotherapy. In: Miklavcic, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-26779-1_165-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-26779-1_165-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-26779-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences